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dummy variables or as linear terms. Additional terms were explored to account 
for interactions between domains. Among the candidate models, a random effects 
model with main effects presented as linear terms, terms for level 3 or higher 
in usual activities, pain/discomfort (PD), and anxiety/depression (AD), a term for 
whether dimension was at level 4 or level 5, and the interaction term between PD 
and AD performed better than the other models. ConClusions: This model can 
be used to estimate a Canadian TTO-based EQ-5D-5L value set.
PIH53
DeveloPIng A generIc DescrIPtIve system For cHIlDren’s HeAltH: A 
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objeCtives: Although there are several general valuation tools for health states 
have been developed for adults, there are few of those for children. In addition, it 
is arguable that the health dimensions included in the health descriptive system 
developed in the Western countries are valid in the Eastern countries like Korea. The 
purpose of this study was to elicit health dimensions of children as the first step 
of developing a general valuation tool for children’s health states. Methods: The 
sample was recruited from one elementary school in Cheonan city, Korea. The total 
number of participants was 40: 22 boys and 18 girls, 15 from grade 1 through 3 and 
25 from grade 4 through 6. Interviews were done in a group of 3 to 4 children of the 
same grade. Two trained interviewers asked various open-ended questions includ-
ing “What comes up in your mind when you hear the word ‘health’ and why do you 
think so?” All the interviews were recorded and transcribed. NVivo 10 was used for 
the qualitative analysis. Currently, more samples are recruited from outpatients to 
a university hospital, which will be added to the analysis by the time of the confer-
ence. Results: Over 100 words and phrases that were directly or indirectly related 
to concept of health were extracted. After carefully and repeatedly reviewing these 
words and phrases, we categorized them into similar meaning units. As a result, we 
could obtain 13 themes including food/nutrition, physical activity, usual activities, 
loneliness, depression/anxiety, pain, good mood/joyfulness, robustness/good stat-
ure, playing with friends, family, fear, longevity, disease/treatment. ConClusions: 
The study found new dimensions that had not been included in the previous health 
descriptive systems for children such as food/nutrition, robustness/good stature, 
and family. This implies that children from different cultural backgrounds might 
need different general health descriptive systems.
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objeCtives: In recent years, the time trade-off (TTO) method with a 10-year time 
horizon has been the most frequently used approach for direct health-state util-
ity assessment. It is likely that researchers have favored this method because the 
National Institute of Health and Clinical Excellence (NICE) Guide to the Methods 
of Technology Appraisal states a preference for consistency with the EQ-5D, which 
has a utility scoring algorithm derived using 10-year TTO valuations. Although com-
parability to previous utility studies is important, there are situations when the 
10-year TTO is not optimal. Methods: A review of the literature was conducted 
to identify situations when TTO with a 10-year time horizon may not be the most 
appropriate method for eliciting health-state utilities. Results: Five challenges to 
the 10-year TTO method include mild health states, small differences among health 
states, temporary health states, pediatric health states, and assessment of samples 
with particular characteristics. In these situations, the 10-year TTO may not yield 
valid utility scores, detect small but important differences among health states, or 
accurately represent the clinical condition being studied. Alternative approaches 
are suggested, including variations of the TTO (e.g., varying the time horizon), other 
direct utility assessment methods (e.g., standard gamble with or without chaining), 
measures developed specifically for children, mapping condition-specific health-
related quality of life questionnaires to generic preference measures, and condi-
tion-specific preference-based measures derived from longer condition-specific 
questionnaires using Rasch and item-response theory methods. ConClusions: 
Rather than simply using the most commonly used method, it is recommended that 
investigators select a utility assessment method based on its relevance and validity 
for particular clinical contexts and health states. Pilot studies are often helpful in 
identifying the optimal approach.
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objeCtives: The US Panel on Cost-Effectiveness recommends excluding productiv-
ity losses from numerators of cost-effectiveness ratios. This critical literature review 
evaluated evidence as to whether individuals consider work loss when completing 
utility assessments reflected in the denominator. Methods: PubMed/MEDLINE, 
Cochrane, and EMBASE databases were searched using terms such as “quality of 
life”, “productivity”, “utility”, and “EQ-5D”. Titles/abstracts of 1,114 identified stud-
ies were double screened using pre-defined criteria. References from key articles 
were manually reviewed. Sixteen relevant publications were identified. Results: 
Nine studies representing 6 countries (Australia (1), Japan (1), The Netherlands (4), 
Sweden (1), Switzerland (1), United States (1)) asked respondents if they sponta-
neously considered income effects or believed study health states would impact 
income. Between 31% and 64% of respondents in 6 studies indicated they considered 
lost income effects in health state valuations in situations where they had been 
HIT interventions. Research evaluating the long term health and cost outcomes of 
improving medication adherence using HIT interventions is also recommended.
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objeCtives: Very limited data exist on patient persistence with testosterone 
replacement therapy (TRT). Furthermore, no persistence data are available for the 
long-acting injection (LAI) formulation. Therefore, the objective of this analysis was 
to compare medication persistence and first switching patterns among patients 
initiating LAI with those using other testosterone formulations. Methods: This 
was a retrospective database analysis of 17,385 patients receiving TRT in Germany 
between 2008 and 2012 based on the IMS®Health German Longitudinal Prescriptions 
(LRx) database. The main outcome measure was the percentage of patients who 
were persistent with their index TRT at 24 months from initiation. Results: During 
the study period, patients receiving the LAI remained on their initial therapy sig-
nificantly longer than patients using capsules, gels or short-acting injections (SAIs) 
(p< 0.001). At three months, 70.1% of patients with the LAI were persistent with 
their initial TRT compared with 39.1% of patients receiving the gels and 14.7% 
of patients treated with the SAI. At 24 months, 20.2% of those receiving the LAI 
remained on their initial therapy vs. 9.7%, 5.7% and 0.5% for capsule, gels and SAIs, 
respectively. Sensitivity analyses showed consistent results. A total of 3,115 (17.9%) 
patients switched to a different product, with those starting on a LAI having the 
lowest switching rate (6.2%) and those starting with SAIs having the highest rate 
(24.2%). ConClusions: While persistence with TRT decreased substantially over 
time, treatment with the long-acting injection demonstrated higher persistence 
compared with the gels, capsule, and short-acting injections. Persistence with treat-
ment for low testosterone may be enhanced by the administration of testosterone 
utilizing a technology that prolongs the availability of drug and reduces dosing 
frequency.
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objeCtives: To describe the frequency of and time to dose escalation for incident 
infliximab(IFX) or tociluzumab(TCZ) patients. Methods: This retrospective, obser-
vational analysis used national data from Symphony Health Solutions (SHS). All 
claims for adult IFX or TCZ (index biologic) patients were extracted from January 1, 
2009 to December 31, 2011. Proxy eligibility criteria ensured complete claims and 
excluded pre-index biologic users. IFX and TCZ patients were excluded if their calcu-
lated daily dose was < 200mg or > 1200mg (IFX) and < 200mg or > 800mg (TCZ) or if the 
times between infusions were < 14 days or < 25 days respectively, or if patients had 
biologic claims in both the prescription and procedure (Px) files. Within the first 180 
days post index, patients with ≥ 3 Px claims were classified by their dose change over 
the first 3 dosages, reporting any dose increase, dose doubling at any time, the time 
to dose doubling and the time between claims (infusions). Results are descriptive, 
and cohorts were not adjusted for differences. Results: 25,451 IFX patients (11,948 
RA) and 1593 TCZ patients (1584 RA) contributed data. For overall sample, patients 
with ≥ 3 Px claims (n= 20,131 IFX; n= 1285 TCZ), mean initial doses were 410mg (IFX) 
and 456mg (TCZ). By dose 2, 6.9% of IFX and 22.2% of TCZ patients experienced a 
dose increase. By dose 3, 81.8% of IFX patients and 55.0% of TCZ patients remained 
on the same dose relative to their initial dose. Within 180 days, 4.9% of IFX and 18.0% 
of TCZ patients doubled their initial dose. Median time to dose doubling was 99 days 
(IFX) and 58 days (TCZ). ConClusions: Dose escalation appears to happen more 
frequently and more quickly after patients initiate TCZ than when initiating IFX. 
The excess dose doubling with TCZ may have important economic implications.
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objeCtives: The EQ-5D-5L has the same five domains as in the EQ-5D but with 
5 response options reflecting no, mild, moderate, severe, and extreme problems 
in each domain. The primary objective of this study was to develop a value set of 
the EQ-5D-5L in Canada. Methods: The combination of traditional and lead-time 
time trade-off (TTO) was one of the main valuation techniques. A total of 80 health 
states plus the 5 very mild states (with only one dimension at level 2) randomly 
grouped into 10 blocks were evaluated using the TTO. State “55555”was included in 
every block. Each participant was asked to complete one block of 10 states through 
a face-to-face interview. Quota sampling was used to select a representative sam-
ple from the Canadian general population in terms of gender, age, and education. 
Interviews were conducted in Vancouver, Edmonton, Montreal and Hamilton 
between November 2012 and September 2013. Various functional forms and model 
estimators were used to estimate a TTO-based value set. Results: A total of 1209 
participants completed the interview with the mean age of 47.6 years and 54.8% 
being female. Candidate models were compared using face validity (severer states 
have lower values), mean absolute error (MAE), mean squared error (MSE), and 
Akaike Information Criterion (AIC). The main effects were presented using either 
